Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
Stem cell gene therapy approaches for Human Immunodeficiency Virus (HIV) infection have been explored in clinical trials and several anti-HIV genes delivered by retroviral vectors were shown to block HIV replication. However, gammaretroviral and lentiviral based retroviral vectors have limitations f...
Main Authors: | Arun K. Nalla, Grant D. Trobridge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/4/2/8 |
Similar Items
-
Structural and Functional Insights into Foamy Viral Integrase
by: Cha-Gyun Shin, et al.
Published: (2013-07-01) -
Large Animal Models for Foamy Virus Vector Gene Therapy
by: Peter A. Horn, et al.
Published: (2012-12-01) -
Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells
by: Clara Marie Munz, et al.
Published: (2022-09-01) -
Orthoretroviral-like prototype foamy virus gag-pol expression is compatible with viral replication
by: Reh Juliane, et al.
Published: (2011-08-01) -
The First Co-Opted Endogenous Foamy Viruses and the Evolutionary History of Reptilian Foamy Viruses
by: Pakorn Aiewsakun, et al.
Published: (2019-07-01)